NO911432L - Fremgangsmaate for fremstilling av 3,5-disubstituerte 2-isoksazoliner og isoksazoler. - Google Patents

Fremgangsmaate for fremstilling av 3,5-disubstituerte 2-isoksazoliner og isoksazoler.

Info

Publication number: NO911432L
Authority: NO; Norway
Prior art keywords: isoxsazolines; isoxsazoles; disubstituted; procedure; preparation
Prior art date: 1990-04-12

Application number

NO91911432A

Other languages

English (en)

Norwegian (no)

Other versions

NO911432D0 (no

Inventor

Wilfried Schwab

Hiristo Anagnostopulos

Elena Porsche-Wiebking

John Grome

Original Assignee

Hoechst Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-04-12

Filing date

1991-04-11

Publication date

1991-10-14

1991-04-11 Application filed by Hoechst Ag filed Critical Hoechst Ag

1991-04-11 Publication of NO911432D0 publication Critical patent/NO911432D0/no

1991-10-14 Publication of NO911432L publication Critical patent/NO911432L/no

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/04—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
- C07F9/653—Five-membered rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Psychiatry (AREA)
Heart & Thoracic Surgery (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Urology & Nephrology (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Plural Heterocyclic Compounds (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO91911432A 1990-04-12 1991-04-11 Fremgangsmaate for fremstilling av 3,5-disubstituerte 2-isoksazoliner og isoksazoler. NO911432L (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE4011880		1990-04-12

Publications (2)

Publication Number	Publication Date
NO911432D0 NO911432D0 (no)	1991-04-11
NO911432L true NO911432L (no)	1991-10-14

Family

ID=6404301

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO91911432A NO911432L (no)	1990-04-12	1991-04-11	Fremgangsmaate for fremstilling av 3,5-disubstituerte 2-isoksazoliner og isoksazoler.

Country Status (16)

Country	Link
US (1)	US5273989A (cs)
EP (1)	EP0451790A1 (cs)
JP (1)	JPH04234857A (cs)
KR (1)	KR910018363A (cs)
CN (1)	CN1055537A (cs)
AU (1)	AU7428591A (cs)
BR (1)	BR9101475A (cs)
CA (1)	CA2040219A1 (cs)
CS (1)	CS101391A2 (cs)
FI (1)	FI911718A7 (cs)
HU (1)	HU911183D0 (cs)
IE (1)	IE911235A1 (cs)
IL (1)	IL97821A0 (cs)
NO (1)	NO911432L (cs)
PT (1)	PT97329A (cs)
ZA (1)	ZA912701B (cs)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1994020475A1 (fr) *	1993-03-02	1994-09-15	Fujisawa Pharmaceutical Co., Ltd.	Derive d'isoxazole
PL314605A1 (en) *	1993-11-26	1996-09-16	Pfizer	Isoxazolin compounds as anti-inflammatory agents
JP2818820B2 (ja) *	1993-11-26	1998-10-30	ファイザー・インク．	抗炎症剤としての３−アリール−２−イソオキサゾリン類
US5767118A (en) *	1994-10-26	1998-06-16	Merck & Co., Inc.	4-Heterocyclic peperidines promote release of growth hormone
FR2752163B1 (fr) *	1996-08-12	1998-10-30	Pf Medicament	Utilisation de l'efaroxan pour la fabricaton de medicament destine au traitement de la maladie de huntington
KR19990011062A (ko) *	1997-07-21	1999-02-18	손욱	이소옥사졸리딘 고리 함유 액정화합물 및 이를 포함하고 있는 액정 조성물
US6319937B1 (en) *	1998-11-18	2001-11-20	Dupont Pharmaceuticals Company	Isoxazoline fibrinogen receptor antagonists
MXPA02002578A (es)	1999-09-08	2002-10-23	Guilford Pharm Inc	Compuestos de union a ciclofilina no peptidicos, y su uso.
EP1360173A2 (en)	2001-01-25	2003-11-12	Guilford Pharmaceuticals Inc.	Trisubstituted carbocyclic cyclophilin binding compounds and their use
AU2003221322A1 (en) *	2002-03-07	2003-09-16	Sds Biotech K.K.	Substituted isoxazole alkylamine derivative and agri- and horticultural fungicide
JP4754487B2 (ja) *	2003-08-20	2011-08-24	エミスフィアーテクノロジーズインコーポレイテッド	グルカゴン様ペプチド（ｇｌｐ）−１化合物またはメラノコルチン４受容体（ｍｃ４）アゴニストペプチドの経口デリバリーのための化合物、方法および製剤
CA2532026C (en)	2003-08-20	2012-04-17	Eli Lilly And Company	Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide
WO2006054102A1 (en) *	2004-11-19	2006-05-26	Plant Bioscience Limited	Microcin b17 analogs and methods for their preparation and use
JP2010533644A (ja) *	2007-05-31	2010-10-28	聡美庭山	ハーフエステルの合成方法
US8927551B2 (en) *	2009-05-18	2015-01-06	Infinity Pharmaceuticals, Inc.	Isoxazolines as inhibitors of fatty acid amide hydrolase
US9149465B2 (en) *	2009-05-18	2015-10-06	Infinity Pharmaceuticals, Inc.	Isoxazolines as inhibitors of fatty acid amide hydrolase
US8765735B2 (en) *	2009-05-18	2014-07-01	Infinity Pharmaceuticals, Inc.	Isoxazolines as inhibitors of fatty acid amide hydrolase
ES2907626T3 (es) *	2015-02-27	2022-04-25	Seed Res Institute Co Ltd	Método para producir kakeromicina y sus derivados
WO2018089353A1 (en) *	2016-11-08	2018-05-17	Bristol-Myers Squibb Company	3-substituted propionic acids as alpha v integrin inhibitors
CN111333590B (zh) *	2018-12-18	2022-05-17	沈阳中化农药化工研发有限公司	一种异恶唑烷盐酸盐的制备方法
CN113149926B (zh) *	2021-04-30	2023-05-26	华侨大学	一种3,5-二取代异恶唑衍生物的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA826165A (en) *		1969-10-28	Gagneux Andre	Process for the production of an isoxazole derivative
US3152139A (en) *	1961-10-17	1964-10-06	Geigy Chem Corp	Certain aminoisoxazolone derivatives
CH450423A (de) *	1965-06-03	1968-01-31	Geigy Ag J R	Verfahren zur Herstellung von 3-Hydroxy-5-aminomethyl-isoxazol
DK150615C (da) *	1982-10-26	1987-11-09	Cheminova As	Fremgangsmaade til fremstilling af substituerede 3-isoxazololer
CA1261335A (en) *	1984-08-29	1989-09-26	Hoffmann-La Roche Limited/Hoffmann-La Roche Limitee	Ethylenediamine monoamide derivatives
EP0317588B1 (en) *	1987-05-20	1991-08-07	ZAMBON GROUP S.p.A.	Isoxazoles with nootropic activity
DE3736113A1 (de) *	1987-10-26	1989-05-03	Hoechst Ag	Arzneimittel, darin enthaltene phosphorhaltige 2-isoxazoline und isoxazole, sowie herstellungsverfahren fuer diese heterocyclischen verbindungen
DE3914969A1 (de) *	1989-05-02	1990-11-08	Schering Ag	5-substituierte 3-arylisoxazol-derivate, deren herstellung und verwendung als schaedlingsbekaempfungsmittel
JP2786683B2 (ja) *	1989-08-15	1998-08-13	三共株式会社	グリコール誘導体およびその用途

1991
- 1991-04-09 EP EP91105614A patent/EP0451790A1/de not_active Withdrawn
- 1991-04-10 IL IL97821A patent/IL97821A0/xx unknown
- 1991-04-10 FI FI911718A patent/FI911718A7/fi unknown
- 1991-04-10 US US07/683,068 patent/US5273989A/en not_active Expired - Fee Related
- 1991-04-10 CS CS911013A patent/CS101391A2/cs unknown
- 1991-04-10 KR KR1019910005696A patent/KR910018363A/ko not_active Withdrawn
- 1991-04-11 CA CA002040219A patent/CA2040219A1/en not_active Abandoned
- 1991-04-11 ZA ZA912701A patent/ZA912701B/xx unknown
- 1991-04-11 IE IE123591A patent/IE911235A1/en unknown
- 1991-04-11 JP JP3105156A patent/JPH04234857A/ja active Pending
- 1991-04-11 PT PT97329A patent/PT97329A/pt not_active Application Discontinuation
- 1991-04-11 AU AU74285/91A patent/AU7428591A/en not_active Abandoned
- 1991-04-11 CN CN91102287A patent/CN1055537A/zh active Pending
- 1991-04-11 HU HU911183A patent/HU911183D0/hu unknown
- 1991-04-11 BR BR919101475A patent/BR9101475A/pt unknown
- 1991-04-11 NO NO91911432A patent/NO911432L/no unknown

Also Published As

Publication number	Publication date
CA2040219A1 (en)	1991-10-13
ZA912701B (en)	1991-12-24
IL97821A0 (en)	1992-06-21
US5273989A (en)	1993-12-28
FI911718L (fi)	1991-10-13
BR9101475A (pt)	1991-11-26
JPH04234857A (ja)	1992-08-24
NO911432D0 (no)	1991-04-11
PT97329A (pt)	1992-01-31
CS101391A2 (en)	1991-11-12
EP0451790A1 (de)	1991-10-16
CN1055537A (zh)	1991-10-23
AU7428591A (en)	1991-10-17
IE911235A1 (en)	1991-10-23
FI911718A0 (fi)	1991-04-10
KR910018363A (ko)	1991-11-30
FI911718A7 (fi)	1991-10-13
HU911183D0 (en)	1991-10-28

Publication	Publication Date	Title
NO911432D0 (no)	1991-04-11	Fremgangsmaate for fremstilling av 3,5-disubstituerte 2-isoksazoliner og isoksazoler.
NO913234L (no)	1992-02-21	Fremgangsmaate for fremstilling av pyrazolderivater.
NO910766L (no)	1991-09-02	Fremgangsmaate for fremstilling av titandioksyd.
NO912346L (no)	1991-12-19	Fremgangsmaate for fremstilling av aminobenzodiazepiner.
NO890269D0 (no)	1989-01-20	Fremgangsmaate for fremstilling av 1,4-disubstituerte-piperidinyl-forbindelser.
NO894539D0 (no)	1989-11-14	Fremgangsmaate for fremstilling av nye 2'-halomethyliden-,2'-ethenyliden- og 2'-ethynylcytidin-, uriden og guanosinderivater.
NO893826D0 (no)	1989-09-26	Fremgangsmaate for fremstilling av 2'-halomethyliden, 2'-ethenyliden og 2'-ethenyladenosinderivater.
NO902548L (no)	1990-12-10	Fremgangsmaate for fremstilling av fenamat-1,3,4-tiadiazoler og 1,3,4 oksadiazoler.
NO900643D0 (no)	1990-02-09	Fremgangsmaate for fremstilling og anvendelse av 2,3,23-trihydroksi-urs-12-ener og deres derivater.
NO892499L (no)	1989-08-16	2,5,6,7-tetranor-4,8-inter-m-fenylen pgi2 derivater, fremgangsmaate for fremstilling av disse, og anvendelse derav.
NO903347D0 (no)	1990-07-27	Fremgangsmaate for fremstilling av 14,17alfa-ethano- og ethanooestratriener.
NO882335L (no)	1988-11-30	Fremgangsmaate for fremstilling av 5-(omega-ammonio-acyloksy-metylen)-tetrahydrofuraner og -tetrahydrotiofener.
NO911543D0 (no)	1991-04-18	Katalysatorsystem og fremgangsmaate for fremstilling av 1,2-diklorethan.
NO921086L (no)	1992-10-06	Fremgangsmaate for fremstilling og anvendelse av substituerte 2',3'-didesoksy-5-trifluormetyluridiner
NO880409D0 (no)	1988-01-29	Fremgangsmaate for fremstilling av 14,15-substituerte lanosteroler.
NO911672L (no)	1991-10-28	Fremgangsmaate for fremstilling av alkansulfonanilid-derivater.
NO904108D0 (no)	1990-09-20	Fremstilling av 2,6-dioksypiperidinderivater.
NO891987D0 (no)	1989-05-18	Fremgangsmaate for fremstilling av n-substituerte fenyltioaniliner, fenylsulfinylaniliner og fenylsulfonylaniliner.
NO901597D0 (no)	1990-04-09	Tannstikker og fremgangsmaate til fremstilling av samme.
NO901859D0 (no)	1990-04-26	Festebaand, samt fremgangsmaate for fremstilling av slikt festebaand.
NO913456D0 (no)	1991-09-03	Fremgangsmaate for fremstilling av 2',3'-dideoksy-2',3'-didehydronukleosider.
NO913459L (no)	1989-09-25	Fremgangsmaate for fremstilling av 2',3'-dideoksy-2',3'-didehydronukleosider.
NO913457D0 (no)	1991-09-03	Fremgangsmaate for fremstilling av 2',3'-dideoksy-2',3'-didehydronukleosider.
NO913458D0 (no)	1991-09-03	Fremgangsmaate for fremstilling av 2',3'-dideoksy-2',3'-didehydronukleosider.
NO883526L (no)	1989-02-22	Framgangsmaate for framstilling av 1,5-benzotiazepinderivater.